Main
>
RHEUMATOLOGY>RHEUMATOID ARTHRITIS
>
Treatment
>
p38 MAP Kinase Inhibitor Program
>
Compound (Co.: USA. S)
>
Clinical Status: Phase IIa
Clinical Status: Phase IIa's products
This section has no products